RecallRadar

FDA Device recall Z-0285-2018

Rx series HbA1c REF/Catalog Number HA3830, GTIN 05055273203561, IVD

On 2018-01-03 the FDA classified a Class II recall of Rx series HbA1c REF/Catalog Number HA3830, GTIN 05055273203561, IVD by Randox Laboratories, citing randox confirmed low calibration absorbance with HbA1c, Catalog Number HA3830, Batch 414553. The reagent may not continue to meet its specific performance characteristics througho….

Read the official FDA Device notice

AgencyFDA Device
Recall numberZ-0285-2018
ClassificationClass II
Statusterminated
Initiated2017-06-07
Published2018-01-03
Last updated2026-09-13 11:54 UTC
CompanyRandox Laboratories
DistributionPR

Product

Rx series HbA1c REF/Catalog Number HA3830, GTIN 05055273203561, IVD; -- RANDOX LABORATORIES LTD. , This product is suitable for use on RX series instruments which includes the RX Daytona and RX Imola analysers. Packaging Format: HbA1c R1: Antibody Reagent - 3 x 14 ml HbA1c R2: Agglutinator Reagent - 3 x 14 ml R3: Haemoglobin Denaturant Reagent - 3 x 50 ml Hb R1: Total Haemoglobin Reagent - 3 x 28 ml For Professional Use in the quantitative in vitro determination of Haemoglobin A1c concentration in whole blood.

Reason

Randox confirmed low calibration absorbance with HbA1c, Catalog Number HA3830, Batch 414553. The reagent may not continue to meet its specific performance characteristics throughout the shelf life of the product.

Identifiers

code_infoLot/Batch 414553, expiry 28th Jan 2019

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:54 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0285-2018%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.